Kevin M. Picardat

Array ( [id] => 1545716 [patent_doc_number] => 06444645 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Crosslink-stabilized indolicidin analogs' [patent_app_type] => B1 [patent_app_number] => 09/099631 [patent_app_country] => US [patent_app_date] => 1998-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10919 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444645.pdf [firstpage_image] =>[orig_patent_app_number] => 09099631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908613 [patent_doc_number] => 20010011380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'HYPERSENSITIVE RESPONSE ELICITOR FRAGMENTS ELICITING A HYPERSENSITIVE RESPONSE AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/086118 [patent_app_country] => US [patent_app_date] => 1998-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19418 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011380.pdf [firstpage_image] =>[orig_patent_app_number] => 09086118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736614 [patent_doc_number] => 07033765 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-25 [patent_title] => 'Site-specific drug delivery' [patent_app_type] => utility [patent_app_number] => 09/367794 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 16818 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033765.pdf [firstpage_image] =>[orig_patent_app_number] => 09367794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319162 [patent_doc_number] => 06605594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Aqueous glycerol formulations of somatotropin' [patent_app_type] => B2 [patent_app_number] => 09/001644 [patent_app_country] => US [patent_app_date] => 1997-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2075 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605594.pdf [firstpage_image] =>[orig_patent_app_number] => 09001644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 729107 [patent_doc_number] => 07041785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-09 [patent_title] => 'B1-bradykinin receptor antagonists and use thereof' [patent_app_type] => utility [patent_app_number] => 09/242751 [patent_app_country] => US [patent_app_date] => 1997-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 11989 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041785.pdf [firstpage_image] =>[orig_patent_app_number] => 09242751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1166205 [patent_doc_number] => 06756355 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'HMGI proteins in cancer and obesity' [patent_app_type] => B1 [patent_app_number] => 08/852666 [patent_app_country] => US [patent_app_date] => 1997-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 28 [patent_no_of_words] => 24114 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756355.pdf [firstpage_image] =>[orig_patent_app_number] => 08852666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265557 [patent_doc_number] => 06660837 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Modified protein derived from protein kinase N' [patent_app_type] => B1 [patent_app_number] => 08/685852 [patent_app_country] => US [patent_app_date] => 1996-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 49 [patent_no_of_words] => 35658 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660837.pdf [firstpage_image] =>[orig_patent_app_number] => 08685852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760744 [patent_doc_number] => 20030124105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'PROGRAMMED CELL DEATH GENES AND PROTEINS' [patent_app_type] => new [patent_app_number] => 08/459455 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 28831 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124105.pdf [firstpage_image] =>[orig_patent_app_number] => 08459455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 167289 [patent_doc_number] => 07666436 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-02-23 [patent_title] => 'Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines' [patent_app_type] => utility [patent_app_number] => 08/431673 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 14480 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666436.pdf [firstpage_image] =>[orig_patent_app_number] => 08431673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1217392 [patent_doc_number] => 06706873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines' [patent_app_type] => B1 [patent_app_number] => 08/316765 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 39 [patent_no_of_words] => 28069 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706873.pdf [firstpage_image] =>[orig_patent_app_number] => 08316765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 797818 [patent_doc_number] => 07427404 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-23 [patent_title] => 'Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines' [patent_app_type] => utility [patent_app_number] => 08/261691 [patent_app_country] => US [patent_app_date] => 1994-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 14055 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427404.pdf [firstpage_image] =>[orig_patent_app_number] => 08261691 [rel_patent_id] =>[rel_patent_doc_number] =>)